Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Gut Pathogens|June 14, 2025
Risk factors and outcomes of Clostridioides difficile infection in patients with colorectal cancer: critical perspective in managementHamideh Raeisi, Spigaglia Patrizia, Amir Sadeghi, et al.
Infectious Diseases and Therapy|February 29, 2024
Oritavancin Versus Daptomycin for Osteomyelitis Treatment After Surgical DebridementNicholas W Van Hise, Russell M Petrak, Kairav Shah, et al.
Drugs in R&D|November 27, 2014
Stability and recovery of DIFICID(®) (Fidaxomicin) 200-mg crushed tablet preparations from three delivery vehicles, and administration of an aqueous dispersion via nasogastric tubeAnna Tousseeva, J Derek Jackson, Mark Redell, et al.
International Journal of Antimicrobial Agents|June 11, 2016
Ridinilazole: a novel therapy for Clostridium difficile infectionRichard J Vickers, Glenn Tillotson, Ellie J C Goldstein, et al.
Anaerobe|October 20, 2025
Microbiome and metabolome changes after fecal microbiota, live-jslm, administration are associated with health-related quality of life improvementsRohan Mishra, Adam Harvey, Amy Guo, et al.
Anaerobe|January 12, 2024
Bacteroides and related species: The keystone taxa of the human gut microbiotaJae Hyun Shin, Glenn Tillotson, Tiffany N MacKenzie, et al.
Open Forum Infectious Diseases|July 7, 2018
A Real-world Patient Registry for Oritavancin Demonstrates Efficacy and Safety Consistent With the Phase 3 SOLO ProgramMark Redell, Greg Moeck, Christopher Lucasti, et al.
Emerging Infectious Diseases|May 23, 2020
Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020Avnish Sandhu, Glenn Tillotson, Jordan Polistico, et al.
Probiotics and Antimicrobial Proteins|August 7, 2026
Live Biotherapeutic Products (LBPs) as Promising Microbiome-Based Medicines for Colorectal Cancer (CRC): Mechanistic Basis, Therapeutic Applications, and Translational ChallengesSamira Nomiri, Farzaneh Yazdani, Hamed Heidary, et al.
Advances in Therapy|May 21, 2023
Economic Impact of Recurrent Clostridioides difficile Infection in the USA: A Systematic Literature Review and Cost SynthesisKelly R Reveles, Min Yang, Viviana Garcia-Horton, et al.
Pageof 6